Cellectis has released its financial results for the second quarter of 2026. The report also highlighted advancements in the company's ongoing clinical trials.
Cellectis Announces Second Quarter 2026 Financial Results
earningsbiotechclinical-trialsQ2-resultspharmaceuticals

